Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.41 |
| ▸ | MAPT | P10636 | 2/20 | 0.41 |
| ▸ | TET2 | Q6N021 | 1/20 | 0.33 |
| ▸ | CES2 | O00748 | 3/20 | 0.33 |
| ▸ | ACHE | P22303 | 3/20 | 0.33 |
| ▸ | CES1 | P23141 | 3/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | XBP1 | P17861 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | GPR35 | Q9HC97 | 1/20 | 0.31 |
| ▸ | CA2 | P00918 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL305583 | 0.74 | ALDH1A1 (0.56) | ALDH1A1MAPTTET2CA2 | |
| SCHEMBL305582 | 0.74 | ALDH1A1 (0.56) | ALDH1A1MAPTTET2CA2 | |
| SCHEMBL11147178 | 0.74 | ALDH1A1 (0.56) | ALDH1A1MAPTTET2CA2 | |
| Ammonia Solution, Strong SCHEMBL7633955 | 0.72 | ALDH1A1 (0.53) | ALDH1A1MAPTTET2CA2 | |
| Ammonia Solution, Strong SCHEMBL6537012 | 0.72 | ALDH1A1 (0.53) | ALDH1A1MAPTTET2CA2 | |
| SCHEMBL15546439 | 0.70 | ALDH1A1 (0.46) | ALDH1A1MAPTTET2 | |
| SCHEMBL7771273 | 0.70 | ALDH1A1 (0.46) | ALDH1A1MAPTTET2 | |
| SCHEMBL486217 | 0.70 | ALDH1A1 (0.41) | ALDH1A1MAPTTET2CES2ACHE | |
| SCHEMBL11742979 | 0.70 | — | — | |
| SCHEMBL5843191 | 0.70 | ALDH1A1 (0.46) | ALDH1A1MAPTTET2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2239281-A2 | Novel polymer and method for determining cholesterol using the same | Wako Pure Chemical Industries, Ltd. (JP) | 2010-10-13 | — | — | EP | claimed |
| EP-1903069-A1 | NOVEL POLYMER AND METHOD OF MEASURING CHOLESTEROL THEREWITH | Wako Pure Chemical Industries, Ltd. (JP) | 2008-03-26 | — | — | EP | claimed |
| US-11133529-B2 | Fluorinated acrylates as additives for Li-ion battery electrolytes | GOTION, INC. (US) | 2021-09-28 | — | — | US | disclosed |
| WO-2017050609-A1 | FLUORINATED ACRYLATES AS ADDITIVES FOR Li-ION BATTERY ELECTROLYTES | BASF SE (DE) | 2017-03-30 | — | — | WO | disclosed |
| US-8158375-B2 | Polymer and method of measuring cholesterol therewith | WAKO PURE CHEMICAL INDUSTRIES, LTD. (JP) | 2012-04-17 | — | — | US | disclosed |
| EP-2420871-A1 | POLYMERIZABLE COMPOSITION FOR COLOR FILTER, COLOR FILTER, AND SOLID IMAGING ELEMENT | FUJIFILM Corporation (JP) | 2012-02-22 | — | — | EP | disclosed |
| US-20090215097-A1 | Novel Polymer and Method of Measuring Cholesterol Therewith | WAKO PURE CHEMICAL INDUSTRIES, LTD. (JP) | 2009-08-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11133529-B2 | Fluorinated acrylates as additives for Li-ion battery electrolytes | HCN3, KCNN4, OR10J3 | ALDH1A1 1705/4885MAPT 4609/4885TET2 3368/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.